The difference in the GLP-1 treatment responses could be ascribed to a different pathophysiology of type 2 diabetes, namely, lower insulin secretory function and less insulin resistance, lower body mass index, different genetic makeups, preserved incretin effect and different food compositions in East Asians compared with other ethnic groups [21]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.